RCKT (Rocket Pharmaceuticals) Institutional Ownership: 96.82% (As of Jul. 12, 2026)


RCKT Rocket Pharmaceuticals Inc RCKT
21 GF Score
Price $3.91
! 3 Warning Signs
View Full Analysis

What is Rocket Pharmaceuticals Institutional Ownership?

Rocket Pharmaceuticals RCKT -6.68% 21 Institutional Ownership is 96.82% as of Jul. 12, 2026. GuruFocus rates RCKT with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Rocket Pharmaceuticals's institutional ownership is 96.82%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Rocket Pharmaceuticals's Insider Ownership is 3.95%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Rocket Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 81.49%.

Rocket Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Rocket Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rocket Pharmaceuticals Institutional Ownership Chart

Rocket Pharmaceuticals Historical Data

The historical data trend for Rocket Pharmaceuticals can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 26.30 25.72 25.89 25.33 25.02 25.78 30.70 31.33 31.66 29.93
RCKT
21GF Score
Rocket Pharmaceuticals Inc RCKT
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rocket Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 96.82% mean?
Rocket Pharmaceuticals (RCKT) has a Institutional Ownership of 96.82% as of Jul. 12, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Rocket Pharmaceuticals and its competitors.
Is Rocket Pharmaceuticals' Institutional Ownership too high?
Rocket Pharmaceuticals' current Institutional Ownership is 96.82%. Overall, Rocket Pharmaceuticals has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Rocket Pharmaceuticals' Institutional Ownership compare to TENX and DMAC?
Rocket Pharmaceuticals' Institutional Ownership of 96.82% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Rocket Pharmaceuticals and its competitors. Rocket Pharmaceuticals's current Institutional Ownership is 96.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rocket Pharmaceuticals stock overvalued right now?
Rocket Pharmaceuticals (RCKT) has a current Institutional Ownership of 96.82%. The current Institutional Ownership is 96.82%. Rocket Pharmaceuticals' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Rocket Pharmaceuticals (RCKT), the current Institutional Ownership is 96.82% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rocket Pharmaceuticals Business Description

Other Exchanges 9IP1:Germany
Address 9 Cedarbrook Drive, Cranbury, NJ, USA, 08512
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
21GF Score

Get the complete analysis for RCKT

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.91
Price